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Introduction 
Adult Onset Still's Disease (AOSD) is a rare systemic inflammatory disorder characterized by 
daily fever, inflammatory polyarthritis, and a transient salmon-pink maculopapular rash. AOSD 
is alternatively known as systemic onset juvenile idiopathic arthritis. Even though there is no 
specific diagnostic test, a serum ferritin level more than 1000ng/ml is common in AOSD. 
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Etiology 
The etiology of AOSD is unknown. The hypothesis remains that AOSD is a reactive syndrome in 
which various infectious agents may act as triggers in a genetically predisposed host. Both 
genetic factors and a variety of viruses, bacteria like Yersinia enterocolitica and Mycoplasma 
pneumonia and other infectious factors have been suggested as important[1][2]. There is 
uncertainty regarding the presence of same etiopathogenic factors among all the AOSD patients. 
A French study of 62 patients showed the association of AOSD with HLA antigen subtypes[3]. 
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Epidemiology 
Adult-onset Still's disease is a very uncommon disease. Its annual incidence has been estimated 
to be 0.1 to 0.4 cases per 100,000 people in Europe. Females are affected slightly more than 
males. It has bimodal age distribution, the first peak between the ages of fifteen to twenty-five 
and the second between thirty-six to forty-six. However, about three-quarters of the patients 
report the onset of disease between sixteen and thirty-five years of age. 
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Pathophysiology 
There are two immune dysregulations described in the pathogenesis of AOSD. Innate immunity 
with neutrophil and macrophage activation under the effect of proinflammatory cytokine IL-18 is 
one pathway.  A study has shown the upregulation of CD64 in active ASD which is a marker of 
neutrophil activation[4]. Secondly, CD4+ T helper (Th) cells may also play a role in the 
pathogenesis of AOSD with the predominance of Th1 subset over Th2 as seen in a study which 
showed significantly higher expression of interferon-gamma mRNA expression than interleukin-
4 in tissue biopsies[5]. Moreover, the role of Th-17 responses is emerging in the pathogenesis of 
AOSD, and levels of Th-17 related cytokines, interleukins-1,6,17,18,21 and 23 are elevated. 
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History and Physical 
There are three main patterns of the clinical course of adult-onset Still's disease (AOSD) namely 
monophasic, intermittent, and chronic [3][6][7]. There is an approximately equal distribution in 
each category however some studies have shown a chronic articular pattern to be more common. 
It is not uncommon for the first two patterns to evolve into chronic articular [3][8]. 
The primary clinical features are seen in adult-onset Still's disease (ASD) are fever, rash, and 
arthritis or arthralgia. They are seen in about 75 to 95 percent of patients [9]. Other common 
symptoms are myalgia, pharyngitis, lymphadenopathy, and splenomegaly. Less commonly 
observed symptoms are hepatomegaly, pleurisy, pericarditis, and abdominal pain. Fever is 
usually quotidian (daily recurring fever with temperature returning to normal between fever 
spikes) most often occurring late during the day and generally precedes other symptoms. The 
temperature can change by 4ºC within four hours [10]. Approximately 20 percent of cases do not 
have complete defervescence as fever persists between spikes or an additional spike occur in the 
morning(double quotidian fever). It may also present as fever of unknown origin (FUO), and a 
temperature of more than 39.5ºC suggests monophasic pattern more strongly [7]. A rash is 
classically evanescent, salmon-colored, macular or maculopapular which is usually nonpruritic 
and occurs with the fever. It is mainly seen on the trunk and extremities but can also be seen on 
palms, soles, and the face. The rash can sometimes be induced by heat(hot shower or towel) or 
by rubbing the skin(Koebner phenomenon). Arthritis can initially be mild, transient, and 
oligoarticular and may evolve to severe, destructive and symmetric polyarticular forms.[11]. 
Commonly involved joints are the knees, wrists, and ankles, although elbows, proximal 
interphalangeal joints, shoulders, metacarpophalangeal, metatarsophalangeal, hips, distal 
interphalangeal and temporomandibular joints can also be involved. Fusion of the wrist joint is 
characteristic of AOSD but is seen in only a few patients. Myalgia often gets worse with fever 
spikes. It may sometimes be severe and debilitating. Muscle weakness is not present, but case 
reports have described a slight elevation of serum creatine kinase and aldolase. Usually, 
electromyographic studies and muscle biopsies are either normal or may show a nonspecific 
inflammatory myopathy. 
Patients can present with a sore throat at the time of initial evaluation and it frequently recurs 
during a disease flare. Examination in those cases typically reveals severe, nonsuppurative 
pharyngitis with negative bacterial cultures. A review of 341 cases of AOSD has described a sore 
throat in 69% of the patients [12]. Symmetrical slightly tender lymphadenopathy is reported in 
one-third to two-thirds of patients, and splenomegaly in one-third to one-half of patients. Liver 
abnormalities include hepatomegaly ranging from 12 to 45 percent[9] and more commonly 
modest elevations of serum hepatic transaminases and alkaline phosphatase. About 30 to 40 
percent of patients with AOSD have pericarditis, pleural effusions, and transient pulmonary 
infiltrates[8][9][13].  Macrophage activation syndrome occurs in a small minority of patients but 
it may be underdiagnosed as suggested by retrospective studies in which MAS occurred in six 
out of 50 patients and 21 out of 109 patients [14]. Abdominal pain occurs in 1 to 48 percent of 
the patients. Nausea, anorexia, and weight loss can also be seen. 
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Evaluation 
At least seven different variety of classification criteria for AOSD are there for use in research. 
The Japanese standards termed the Yamaguchi criteria has the highest sensitivity amongst 
them [15][16]and is the most commonly used. 
Total of five or more criteria including 2 or more significant criteria have a sensitivity of 96% 
and specificity of 92% to classify a patient as having AOSD. 
Major criteria are as follows: 
 Fever of at least 39°C for at least one week 
 Arthralgia or arthritis for at least two weeks. 
 Nonpruritic salmon-colored rash on trunk/extremities. 
 Granulocytic leukocytosis (10,000/microL or greater). 
Minor criteria are as follows: 
 A sore throat. 
 Lymphadenopathy. 
 Hepatomegaly or splenomegaly. 
 Abnormal liver function tests.Negative tests for RF and ANA. 
The lab findings discussed below are characteristic of AOSD, but not pathognomonic and hence 
their presence along with clinical manifestations will help the clinician in establishing the 
diagnosis after ruling out alternate causes. 
Inflammatory markers, ESR and CRP are elevated in almost all the patients [3]. Leukocytosis, 
generally more than 15,000 cells/microL with a predominance of neutrophils greater than 80%, 
normocytic normochromic anemia and thrombocytosis are the hematological findings. These 
hematological abnormalities can be severe enough to mimic primary hematologic disease. Bone 
marrow biopsy has been reported to show hyperplasia of granulocytic precursors and 
hypercellularity and hemophagocytosis in some cases. Hepatic transaminases can be elevated in 
75 percent of patients and aldolase can also elevate in some due to liver inflammation. 
Ferritin levels are generally higher than five times the upper limits of normal in patients with 
AOSD. Elevated ferritin suggests the presence of the disease with an 80% sensitivity and 46% 
specificity. If combined with a decrease in the proportion of glycosylated ferritin <20%, the 
specificity will rise to 93%. 
Less than 10% of the patients have Antinuclear antibodies (ANA) and rheumatoid factor (RF) 
but generally only in low titer. 
The synovial fluid is usually inflammatory with a mean leukocyte range of 100 to 48,000 
cells/microL [3]. 
Radiographs early in the disease typically are either normal or show slight joint space narrowing 
or periarticular osteopenia. Narrowing of the wrist carpometacarpal and intercarpal joint spaces 
which may progress to bone ankylosis is a classic radiographic finding of adult-onset Still's 
disease (AOSD) [17][18]. 
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Treatment / Management 
The goals of therapy include controlling symptoms and physical signs of inflammation as well as 
laboratory markers of inflammation. It also includes preventing end-organ damage and keeping 
the long term effects of therapy to the minimum. 
The efficacy of treatment interventions for ASD is derived from observational studies and 
clinical experience [6][8][19][20][21]. 
The initial therapeutic decisions are based upon the degree of disease activity and the subsequent 
ones based on the clinical response. 
The mild disease presents with fevers, rash, arthralgias or mild arthritis. The patients with mild 
disease may respond to NSAIDs alone, but most of them require at least a low dose of 
glucocorticoid for better control. The dose of NSAIDs is in anti-inflammatory range. 
The moderate disease presents with debilitating joint symptoms, high-grade fever or internal 
organ involvement which is not life-threatening. The patients with moderate disease severity are 
initially treated with glucocorticoids initiated with prednisone 0.5 to 1 mg/kg per day, depending 
upon disease severity.  Biologic, as well as non-biologic disease-modifying antirheumatic drugs, 
might be needed if the steroids cannot be successfully tapered. Anakinra is favored as the initial 
agent in patients without joint erosions, and methotrexate is preferred in patients with prevalent 
joint disease. 
Those with severe disease have life-threatening organ involvement like cardiac tamponade, 
disseminated intravascular involvement or severe hepatic involvement. Those with severe 
disease require initial therapy with pulse IV methylprednisolone 1000 mg daily for three days, 
and this approach has been proven effective in many case reports and series [19][22][23]. Early 
use of biologic therapy is also recommended in severe disease. Among biologics, IL-1 inhibitor 
Anakinra and IL-6 inhibitor Tocilizumab are more effective than TNF inhibitors.  Limited 
evidence suggests that Canakinumab, Rilonacept, Rituximab, and Abatacept may be effective in 
treating patients who are refractory to therapies as mentioned above.  
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Differential Diagnosis 
The differential diagnosis of adult Still's disease (ASD) is very broad and includes infections, 
malignancy, rheumatologic disorders, and adverse drug reactions. 
Among infectious etiologies, many acute viral infections including parvovirus B19, hepatitis and 
others may cause symptoms similar to AOSD. Bacteremia can also cause fever, elevated white 
cell count and acute phase reactants. 
Among rheumatologic diseases include systemic lupus erythematosus (SLE), rheumatoid 
arthritis (RA) and reactive arthritis also cause elevation of acute phase reactants. Vasculitic 
disorders, like polyarteritis nodosa (PAN), which present with fever, arthralgia, skin lesions, and 
pain in the abdomen can also mimic AOSD. 
Malignancy, especially lymphomas may mimic AOSD given the features of lymphadenopathy, 
fever, and leukocytosis. 
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Prognosis 
The course of AOSD generally follows one of the three patterns - self-limited illness, 
intermittent flares or chronic Still's disease. There are several predictors for the chronicity of the 
disease and the unfavorable outcomes. It includes the presence of an erosive polyarthritis at the 
time of presentation and involvement of shoulders or hips [3][24][10]. The need for systemic 
glucocorticoids for more than two years before routine use of biologics is also considered a poor 
prognostic marker. 
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Complications 
AOSD complications include macrophage activation syndrome, amyloidosis, disseminated 
intravascular coagulopathy, pulmonary arterial hypertension, thrombotic thrombocytopenic 
purpura, and diffuse alveolar hemorrhage. 
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Deterrence and Patient Education 
Adult-onset Still's disease is a rare inflammatory arthritis with fevers, rash and joint pain. 
Sometimes people may have just one episode while in others the symptoms persist. It can affect 
any joint, but most commonly involved are knees, wrists, and ankles. Treatment involves 
nonsteroidal anti-inflammatory drugs, steroids, and biologics depending upon the disease 
severity 
Go to: 
Pearls and Other Issues 
When a patient presents with fever, rash and polyarthralgia, the duration of symptoms can help 
in formulating differentials. Short length suggests an infectious etiology whereas a longer course 
should raise concerns for autoimmune causes. 
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Enhancing Healthcare Team Outcomes  
Adult-onset Still’s disease is in part a diagnosis of exclusion and frequently poses a diagnostic 
challenge. While a Rheumatologist is almost always involved in the care, a team of other 
specialties like Cardiologists, Gastroenterologists, and oncologists plays an essential role in the 
management as the disease can cause complications in multiple organ systems. Nurses have an 
important role in monitoring the patient's vital signs and administering medications. Physical and 
Occupational therapy help with the rehabilitation of the patient given severe joint involvements. 
Since the disease has some life-threatening complications, a detailed history, and physical 
examination is needed for patients when there is a suspicion for AOSD to prevent complications 
and improve the prognosis[25](Level V) 
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Questions 
To access free multiple choice questions on this topic, click here. 
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